[INTERVIEW] 'Microbiome to be game changer in immunotherapy' Posted : 2021-02-15 08:31 Updated : 2021-02-15 08:31 Genome & Company CEO Pae Ji-soo speaks during an interview with The Korea Times at the newspaper's newsroom in Jung-gu, Seoul, Jan. 25. Korea Times photo by Kim Kang-min Genome & Company CEO pursues microbiome healthcare group By Nam Hyun-woo One of the most rapidly growing sectors in the biopharmaceutical industry is microbiome medicine. Big name tycoons including Bill Gates and Mark Zuckerberg have already noticed the potential of microbiomes and either invested or donated money to businesses and research in this field, which is quickly evolving into a new money magnet.